pI: 8.4514 |
Length (AA): 818 |
MW (Da): 95282 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 15 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 170 | 1iq8 (A) | 423 | 582 | 12.00 | 0 | 0.25 | 0.1 | -0.32 |
10 | 179 | 2cx0 (A) | 13 | 180 | 23.00 | 0 | 1 | 0.4 | -1.02 |
713 | 814 | 2if1 () | 25 | 123 | 20.00 | 0 | 0.68 | 0.31 | -1.04 |
1 | 184 | 3r90 (A) | 1 | 185 | 21.00 | 0.000000029 | 1 | 0.498239 | -0.41 |
11 | 176 | 3d79 (A) | 6 | 169 | 30.00 | 0.01 | 1 | 0.437834 | -0.25 |
278 | 585 | 4u06 (A) | 52 | 356 | 21.00 | 0.65 | 1 | 0.399428 | 0.97 |
548 | 723 | 4uos (A) | 2 | 182 | 19.00 | 0.099 | 0.56 | 0.509459 | -1.36 |
731 | 803 | 4mo0 (A) | 26 | 91 | 26.00 | 0.38 | 1 | 0.356542 | -0.55 |
1 | 184 | 3r90 (A) | 1 | 185 | 21.00 | 0.00000014 | 1 | 0.49669 | -0.43 |
11 | 175 | 3d79 (A) | 6 | 168 | 27.00 | 0.0000043 | 1 | 0.492406 | -0.72 |
13 | 175 | 2cx0 (A) | 16 | 176 | 26.00 | 0.0018 | 1 | 0.455955 | -0.38 |
212 | 689 | 2vse (A) | 240 | 795 | 28.00 | 0.0072 | 0.22 | 0.400084 | 1.97 |
320 | 654 | 4u09 (A) | 93 | 406 | 26.00 | 0.063 | 1 | 0.466839 | 0.93 |
475 | 691 | 4tql (A) | 11 | 235 | 17.00 | 0.036 | 0.77 | 0.500131 | -0.59 |
546 | 724 | 4uos (A) | 2 | 182 | 18.00 | 0.19 | 0.36 | 0.480563 | -1.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 8 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 16 hs, merozoite, sporozoite, early ring, late ring, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, gametocyte, early schizont, early trophozoite, late schizont, late trophozoite, Oocyst, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Sporozoite. | Otto TD Zanghi G |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_129088)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G71350 | eukaryotic translation initiation factor SUI1 family protein |
Babesia bovis | BBOV_II005360 | hypothetical protein |
Brugia malayi | Bm1_46640 | Translation initiation factor SUI1 family protein |
Candida albicans | CaO19.12008 | similar to S. cerevisiae YDR117C |
Candida albicans | CaO19.4533 | similar to S. cerevisiae YDR117C |
Caenorhabditis elegans | CELE_C25H3.4 | Protein C25H3.4 |
Cryptosporidium hominis | Chro.40020 | hypothetical protein |
Cryptosporidium parvum | cgd4_70 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0287639 | hypothetical protein |
Drosophila melanogaster | Dmel_CG31426 | CG31426 gene product from transcript CG31426-RA |
Echinococcus granulosus | EgrG_000705100 | eukaryotic translation initiation factor 2d |
Echinococcus granulosus | EgrG_000705200 | eukaryotic translation initiation factor 2d |
Echinococcus multilocularis | EmuJ_000705200 | eukaryotic translation initiation factor 2d |
Echinococcus multilocularis | EmuJ_000705100 | eukaryotic translation initiation factor 2d |
Homo sapiens | ENSG00000143486 | eukaryotic translation initiation factor 2D |
Loa Loa (eye worm) | LOAG_09150 | translation initiation factor SUI1 family protein |
Loa Loa (eye worm) | LOAG_10461 | hypothetical protein |
Mus musculus | ENSMUSG00000026427 | eukaryotic translation initiation factor 2D |
Neospora caninum | NCLIV_011560 | GM12258, related |
Neospora caninum | NCLIV_011570 | Ligatin, related |
Oryza sativa | 4329675 | Os02g0557600 |
Onchocerca volvulus | OVOC9834 | Eukaryotic translation initiation factor 2D homolog |
Plasmodium berghei | PBANKA_0809000 | translation initiation factor SUI1, putative |
Plasmodium falciparum | PF3D7_0907600 | translation initiation factor SUI1, putative |
Plasmodium knowlesi | PKNH_0705400 | translation initiation factor SUI1, putative |
Plasmodium vivax | PVX_098825 | hypothetical protein, conserved |
Plasmodium yoelii | PY04116 | hepatocellular carcinoma-associated antigen 56A |
Saccharomyces cerevisiae | YDR117C | Tma64p |
Schistosoma japonicum | Sjp_0315680 | IPR001950,Translation initiation factor SUI1,domain-containing |
Schistosoma japonicum | Sjp_0020230 | Ligatin, putative |
Schistosoma mansoni | Smp_155400 | ligatin |
Schmidtea mediterranea | mk4.005372.00 | Eukaryotic translation initiation factor 2D |
Schmidtea mediterranea | mk4.012822.00 | Eukaryotic translation initiation factor 2D |
Toxoplasma gondii | TGME49_211410 | translation initiation factor sui1 protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0809000 | Plasmodium berghei | Dispensable | plasmo |
TGME49_211410 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.